High Flow Nasal Therapy System with CO2 Washout Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional High Flow Nasal Therapy (HFNT) is limited to stable hypoxemic patients and does not optimize carbon dioxide (CO2) washout, restricting its use and effectiveness, especially outside hospital settings and for patients with hypercapnic conditions like COPD and OSA.
Innovation Solution
A therapy system that includes a nasal interface for delivering oxygen-enriched gas with adjustable flow rates, a sensor arrangement for measuring arterial CO2 partial pressure, and a controller to iteratively adjust flow rates based on capnograph data to maximize CO2 washout, enabling optimized therapy for a broader range of patients.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If HFNT is used for stable hypoxemic patients, then oxygen therapy effectiveness is improved, but patient population coverage is limited
Solution Approach 1:
The system changes the control parameter from fixed flow rates to variable flow rates that are dynamically adjusted based on real-time capnograph data. By monitoring PaCO2 levels and adjusting total flow rate, oxygen flow rate, and air flow rate accordingly, the system adapts to different patient conditions including hypercapnic patients with COPD and OSA, thereby expanding patient population coverage while maintaining therapy effectiveness
Solution Approach 2:
The system introduces feedback control by continuously monitoring capnograph data (PaCO2 levels) and using this information to adjust the delivery system parameters. The controller receives real-time feedback from the sensor arrangement and iteratively adjusts flow rates to maximize CO2 washout, enabling the system to effectively treat patients with varying respiratory conditions beyond just stable hypoxemic patients
2Device complexity
If fixed flow rates are used in HFNT, then device simplicity is maintained, but CO2 washout optimization is insufficient
Solution Approach 1:
The system implements feedback control where the controller continuously monitors capnograph data and adjusts flow rates to maximize CO2 washout. The sensor arrangement provides real-time feedback on PaCO2 levels, and the controller iteratively adjusts total flow rate, oxygen flow rate, and air flow rate based on this feedback, thereby optimizing CO2 washout effectiveness while maintaining reasonable device simplicity
Solution Approach 2:
The system enables self-service optimization by automatically adjusting flow rates based on real-time capnograph data without requiring manual intervention. The controller autonomously analyzes capnograph features, determines optimal flow rates, and adjusts the delivery system parameters to maximize CO2 washout, reducing the need for complex manual control while achieving optimized therapy
3Reliability
If HFNT is restricted to in-hospital usage, then therapy safety is maintained, but treatment accessibility is reduced
Solution Approach 1:
The system enables home treatment by implementing automated feedback control that continuously monitors capnograph data and adjusts flow rates to maximize CO2 washout. The autonomous operation with real-time monitoring and automatic parameter adjustment maintains therapy safety at home, eliminating the need for constant medical supervision while expanding treatment accessibility to patients' homes
Solution Approach 2:
The system maintains therapy safety through continuous feedback monitoring of capnograph data and real-time adjustment of flow rates. The controller continuously analyzes PaCO2 levels and adjusts oxygen flow, air flow, and total flow to maintain optimal therapy conditions, ensuring safety is maintained even when patients receive treatment at home rather than in a hospital setting
Data Source
AI summary
A therapy system has a nasal cannula patient interface configured to deliver gas to a nasal cavity of a patient and a delivery system for delivering oxygen-enriched breathing gas, comprising air and enrichment oxygen, to the patient interface. A sensor is provided allowing arterial partial pressure of CO2, PaCO2 to be measured or estimated thereby to generate capnograph data, A parameter is determined from the capnograph data which is representative of CO2 washout, and the total flow rate, the oxygen flow rate or the air flow rate of the breathing gas delivered by the delivery system are iteratively adjusted while monitoring the determined parameter. A value of total flow rate, oxygen flow rate or air flow rate is used which maximizes CO2 washout or achieves a desired level of CO2 washout.